论文部分内容阅读
目的观察泮托拉唑联合莫沙必利治疗反流性食管炎疗效。方法 60例确诊为反流性食道炎患者随机分为2组,对照组采用单一泮托拉唑片口服;治疗组采用除上述对照组用药的基础上加莫沙必利片口服。结果治疗组总有效率及症状评分明显优于对照组,差异有统计学意义(P<0.05)。结论在治疗反流性食管炎方面,泮托拉唑联合莫沙必利可有效地减轻症状,促进食管黏膜恢复,提高患者的生活质量,将做为一种安全、有效的方法应用于临床。
Objective To observe the effect of pantoprazole combined with mosapride on reflux esophagitis. Methods Sixty patients with reflux esophagitis were randomly divided into two groups. The control group was orally administered with a single pantoprazole tablet. The treatment group was given oral ganzapride tablets on the basis of the above-mentioned control group. Results The total effective rate and symptom scores of the treatment group were significantly better than those of the control group, with significant difference (P <0.05). Conclusion In the treatment of reflux esophagitis, pantoprazole combined with mosapride can effectively alleviate the symptoms, promote the recovery of esophageal mucosa and improve the quality of life of patients, and will be used as a safe and effective method in clinical practice.